NIH Funding Opportunities
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 min 42 sec ago
Notice of Change to Research Objectives and Award Budget for RFA-AG-20-035 "Building Resources for the Basic Biology of Aging in Health Disparities Research (R24 Clinical Trial Not Allowed)"
Notice NOT-AG-19-043 from the NIH Guide for Grants and Contracts
Notice of Change in Application Due Date for RFA-AG-20-045 "Tailoring Interventions to Improve Preventive Health Service Use (R61/R33 Clinical Trial Required)
Notice NOT-AG-19-042 from the NIH Guide for Grants and Contracts
Notice NOT-MD-20-005 from the NIH Guide for Grants and Contracts
Notice of NHGRI Participation in PAR-19-372, Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed).
Notice NOT-HG-19-026 from the NIH Guide for Grants and Contracts
Notice of NIAAA's Participation in PAR-19-375 "Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)"
Notice NOT-AA-19-022 from the NIH Guide for Grants and Contracts
Notice of Intent to Publish a Funding Opportunity Announcement for Data Harmonization, Curation and Secondary Analysis of Existing Clinical Datasets (R61/R33 Clinical Trial Not Allowed)
Notice NOT-NS-19-071 from the NIH Guide for Grants and Contracts
Notice of Intent to Publish a Funding Opportunity Announcement for Step Up for Substance Use Disorders (SUD): A Drug Target Initiative for Scientists Engaged in Fundamental Research (U18 - Clinical Trial Not Allowed)
Notice NOT-DA-19-076 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-AG-20-037 from the NIH Guide for Grants and Contracts. The Funding Opportunity Announcement (FOA) invites applications seeking to examine the outcomes of care for persons with Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD) through identifying home and community-based services (HCBS) used, as well as barriers to accessing these types of care, and unmet needs of persons with AD/ADRD concerning care and services.
Funding Opportunity RFA-AG-20-038 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to examine the outcomes of care for persons with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) by identifying home- and community-based services (HCBS) used, as well as barriers to accessing these types of care and unmet needs of persons with AD/ADRD concerning care and services in these settings. This R21 FOA is particularly seeking applications that will develop new measurement instruments in this field and ways to improve data quality and access.
Research Networks for the Study of Recovery Support Services for Persons Treated with Medications for Opioid Use Disorder (R24 Clinical Trial Optional)
Funding Opportunity RFA-DA-20-014 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for infrastructure support to advance the development of efficacy and/or effectiveness research on recovery support services for those who were or who are being maintained on medications for the treatment of opioid use disorder. The infrastructure support will facilitate multi-stakeholder (e.g. researchers and students, payors, providers, individuals in recovery) research networks through meetings, conferences, small-scale pilots, data development work, short-term educational opportunities (such as intensive workshops, summer institutes, or visiting scholar programs), and dissemination to encourage growth and development of specified priority areas and to build resources for advancing recovery support services research. Network applications are to support research related to the following priority recovery support services (1) peer-based recovery support, (2) recovery community centers, (3) active recovery communities, (4) recovery residences, (5) education-based recovery support services, and (6) continuing care models, or others proposed by applicants.
Omics-guided Biobehavioral Interventions for Improved Health Outcomes: A Step Forward in Translation (R01 Clinical Trial Optional)
Funding Opportunity PAR-19-377 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to stimulate clinical research that harnesses the wealth of advances in the fields of genomics and other omics (e.g., metabolomics, microbiomics, proteomics, transcriptomics, epigenomics, etc.) to incorporate these advances into translatable, personalized biobehavioral interventions for improved health outcomes.
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
Funding Opportunity PAR-19-376 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage exploratory/developmental research applications that propose to study the development, validation, feasibility, and effectiveness of innovative mobile health (mHealth) interventions or tools specifically suited for low- and middle-income countries (LMICs) that utilize new or emerging technology, platforms, systems, or analytics. The overall goal of the program is to catalyze innovation through multidisciplinary research that addresses global health problems, develop an evidence base for the use of mHealth technology to improve clinical and public health outcomes, and strengthen mHealth research capacity in LMICs. Applicants are required to propose partnerships between at least one U.S. institution and one LMIC institution.
Funding Opportunity PAR-19-374 from the NIH Guide for Grants and Contracts. This FOA allows for applications that propose large-scale, complex research projects with multiple highly integrated components focused on a common research question relevant to aging. Such projects will likely involve an integrated multidisciplinary team of investigators within a single institution or a consortium of institutions.
New to Working with the NIH Grants Process and Policies? Dont Miss the NIH Regional Seminar on Program Funding and Grants Administration Phoenix, AZ Nov. 6-8, 2019
Notice NOT-OD-19-144 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-CA-19-042 from the NIH Guide for Grants and Contracts. This UE5 funding opportunity announcement (FOA) is for a part of the NCIs Informatics Technology for Cancer Research (ITCR) program (https://itcr.cancer.gov/), and establishes an ITCR Education Center to provide education resources that will enhance the use and usability of the informatics tools and resources developed and supported by the ITCR program through education of both the cancer research community as well as informatics tool developers. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development The proposed Center will provide focused education courses in each of the following two areas (1) thematic topics in cancer informatics and (2) informatics tool usability and user support . The courses supporting education in thematic topics in cancer informatics should cover the variety of domains represented by the ITCR program and incorporate ITCR tools as exemplars for applying informatics methods, including, as appropriate, hands-on training on the associated tools and analysis workflows for participants. The courses in informatics tool usability and user support should focus on activities that target the needs of currently funded ITCR investigators, and provide guidance in enhancing the usability and user support of their tools.
Request for Information (RFI) on the Lessons Learned from the Accelerating Medicines Partnership Rheumatoid Arthritis and Lupus (AMP RA/SLE Program)
Notice NOT-AR-19-039 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DK-19-005 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to invite U54 cooperative agreement applications for Cooperative Centers of Excellence in Hematology (CCEH). The NIDDK Hematology Centers Program is designed to increase access to critical research resources and collaboration in the national multidisciplinary research effort to combat nonmalignant hematologic diseases and to study normal hematopoiesis. In addition, it aims to improve cost-effectiveness of preparing critical reagents, maintaining state-of-the-art resources, and running multi-step molecular biologic assays. Each CCEH will support a minimum of three Biomedical Research Cores, an Administrative Core, and an Enrichment Program. The CCEH are expected to work collaboratively with the NIDDK Hematology Central Coordinating Center -- together comprising the NIDDK Hematology Centers Program. By providing state-of-the-art equipment, resources, and expertise to the greater nonmalignant hematology research community, the program will serve as a national hub for nonmalignant hematology research, supporting career development of scientists just beginning their careers in the field and attracting established investigators from other domains. Funded Centers will cooperate with the NIDDK to facilitate research collaborations and interactions within and among Centers and with the wider research community.
Funding Opportunity RFA-HL-21-002 from the NIH Guide for Grants and Contracts. This limited competition Funding Opportunity Announcement (FOA) solicits continued participation as the Bench-to-Bassinet Program Administrative Coordinating Center (ACC) for the NHLBI Cardiovascular Developmental Biology Data Resource Center (CDDRC) (RFA-HL-20-017) and NHLBI Pediatric Cardiac Genomics Consortium (PCGC) (RFA-HL-20-015).
MD-PhD Training Program in Alzheimer's Disease and Related Dementias and the Behavioral and Social Sciences (T32 Clinical Trial Not Allowed)
Funding Opportunity RFA-AG-20-032 from the NIH Guide for Grants and Contracts. NIA's MD-PhD Training Program in Alzheimer's Disease and Its Related Dementias and the Behavioral and Social Sciences is designed to help strengthen the pipeline of physician-scientist leaders dedicated to using social and behavioral science approaches to addressing the nation's challenges posed by Alzheimer's disease and its related dementias (AD/ADRD). This FOA provides support to eligible domestic institutions to develop and implement effective approaches to integrated dual-degree training leading to the award of both an MD and a research doctorate degree (PhD or equivalent, e.g. DSW).
Fertility and Fertility Preservation for Patients with Diseases that Previously Precluded Reproduction (R21 Clinical Trial Optional)
Funding Opportunity RFA-HD-20-021 from the NIH Guide for Grants and Contracts. The purpose of this RFA is to encourage studies on reproductive health, fertility and fertility preservation/treatment options in patients born with a serious chronic condition who can now expect to survive into adulthood healthy enough to consider their reproductive health and fertility options. The underlying pathophysiology of diseases such as sickle cell anemia, thalassemia, and cystic fibrosis, among others, and/or the cumulative effects of their treatment, can compromise reproductive health. This RFA encourages teams of scientists with expertise in the realm of the particular disease and in reproductive health and fertility to work together to understand the effects of the diseases and/or their treatments on parameters of reproductive health, and to identify ways to preserve, protect, or treat and reproductive deficits in these patients.
NIH Funding Opportunities
- Notice of Intent to Publish a Funding Opportunity Announcement for Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Not Allowed)
- Notice of Intent to Publish a Funding Opportunity Announcement for Pathway to Independence Award in Tobacco Regulatory Research (K99/R00 - Independent Clinical Trial Required)
- Notice of NHGRI Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
- Notice of Extension of the Expiration Date for PAR-17-144 "Limited Competition: National Primate Research Centers (P51)"
- Notice of Intent to Publish a Funding Opportunity Announcement for Pilot Effectiveness Trials for Rapid-Acting Interventions for Severe Suicide Risk (R01 Clinical Trial Required)